NIH-funded researchers see extended health span and life span in treated mice
Injecting senescent cells into young mice results in a loss of health and function but treating the mice with a combination of two existing drugs cleared the senescent cells from tissues and restored physical function. The drugs also extended both life span and health span in naturally aging mice, according to a new study in Nature Medicine, published on July 9, 2018. The research was supported primarily by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).
A research team led by James L. Kirkland, M.D., Ph.D., of the Mayo Clinic in Rochester, Minnesota, found that injecting even a small number of senescent cells into young, healthy mice causes damage that can result in physical dysfunction. The researchers also found that treatment with a combination of dasatinib and quercetin could prevent cell damage, delay physical dysfunction, and, when used in naturally aging mice, extend their life span.
“This study provides compelling evidence that targeting a fundamental aging process—in this case, cell senescence in mice—can delay age-related conditions, resulting in better health and longer life,” said NIA Director Richard J. Hodes, M.D. “This study also shows the value of investigating biological mechanisms which may lead to better understanding of the aging process.”
Many normal cells continuously grow, die, and replicate. Cell senescence is a process in which cells lose function, including the ability to divide and replicate, but are resistant to cell death. Such cells have been shown to affect neighboring ones because they secrete several pro-inflammatory and tissue remodeling molecules. Senescent cells increase in many tissues with aging; they also occur in organs associated with many chronic diseases and after radiation or chemotherapy.
Senolytics are a class of drugs that selectively eliminate senescent cells. In this study, Kirkland’s team used a combination of dasatinib and quercetin (D+Q) to test whether this senolytic combination could slow physical dysfunction caused by senescent cells. Dasatinib is used to treat some forms of leukemia; quercetin is a plant flavanol found in some fruits and vegetables.
To determine whether senescent cells caused physical dysfunction, the researchers first injected young (four-month-old) mice with either senescent (SEN) cells or non-senescent control (CON) cells. As early as two weeks after transplantation, the SEN mice showed impaired physical function as determined by maximum walking speed, muscle strength, physical endurance, daily activity, food intake, and body weight. In addition, the researchers saw increased numbers of senescent cells, beyond what was injected, suggesting a propagation of the senescence effect into neighboring cells.
To then analyze whether a senolytic compound could stop or delay physical dysfunction, researchers treated both SEN and CON mice for three days with the D+Q compound mix. They found that D+Q selectively killed senescent cells and slowed the deterioration in walking speed, endurance, and grip strength in the SEN mice.
In addition to young mice injected with senescent cells, the researchers also tested older (20-month-old), non-transplanted mice with D+Q intermittently for 4 months. D+Q alleviated normal age-related physical dysfunction, resulting in higher walking speed, treadmill endurance, grip strength, and daily activity.
Finally, the researchers found that treating very old (24- to 27-month-old) mice with D+Q biweekly led to a 36 percent higher average post-treatment life span and lower mortality hazard than control mice. This indicates that senolytics can reduce risk of death in old mice.
“This is exciting research,” said Felipe Sierra, Ph.D., director of NIA’s Division of Aging Biology. “This study clearly demonstrates that senolytics can relieve physical dysfunction in mice. Additional research will be necessary to determine if compounds, like the one used in this study, are safe and effective in clinical trials with people.”
The researchers noted that current and future preclinical studies may show that senolytics could be used to enhance life span not only in older people, but also in cancer survivors treated with senescence-inducing radiation or chemotherapy and people with a range of senescence-associated chronic diseases.
The Latest on: Senolytics
via Google News
The Latest on: Senolytics
- Cell findings take scientists closer to stopping clock on human agingon June 5, 2022 at 5:00 pm
Studies are already under way in the United States to confirm the safety and efficacy of senolytics, a class of drugs designed to remove the cells, in humans. A research group led by Eiji Hara ...
- Mayo Clinic Students Help Take Research Beyond the Lab and Into Spaceon May 30, 2022 at 5:00 pm
On Friday, April 8, the first all-civilian flight to the International Space Station lifted off from NASA's Kennedy Space Center in Florida. Mayo Clinic research was on board this historic mission to ...
- Simple Treatment May Prevent Long-Term Side Effects of Cancer Radiotherapyon May 25, 2022 at 1:00 am
The researchers wanted to know whether they could prevent such consequences of cancer therapies, through the use of short treatment with senolytics, a class of drugs that specifically eliminate ...
- Senolytic Drug Treatment Prevents Radiotherapy-Induced Premature Ageing in Miceon May 24, 2022 at 1:53 am
Researchers investigating premature aging as a result of radiotherapy found that treating mice with senolytic drugs after radiotherapy could improve and even prevent premature ageing.
- Special drug class could be used to reverse damage from radiotherapy - studyon May 24, 2022 at 1:16 am
According to a peer-reviewed study published in eLife by researchers at Newcastle University, a brief treatment with senolytics, which destroy cells that have been damaged from cancer treatments ...
- One-off treatment shown to prevent long term side effects of cancer radiotherapieson May 23, 2022 at 10:41 am
The researchers wanted to know whether they could prevent such devastating consequences of cancer therapies by a short treatment with senolytics, a class of drugs that specifically eliminate ...
- This Supplement Destroys 'Zombie Cells' and May Increase Your Life Span, Study Showson May 18, 2022 at 3:17 pm
According to a 2020 scientific review published in the Journal of Internal Medicine, senolytics (or senolytic drugs) are a class of drugs that help clear out zombie cells. Zombie cells (which are ...
- UNITY Biotechnology Presentations at ARVO 2022 Showcase UBX1325 as an Investigational Novel Therapeutic Modality for Retinal Vascular Diseaseson May 5, 2022 at 5:03 am
positioning senolytics as a promising new approach for treating retinal vascular diseases,” said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. “A majority of subjects in our Phase 1 ...
- How Aging Affects Your Immune Systemon August 17, 2020 at 1:33 am
"What people are looking at now is the use of drugs called senolytics," Haynes says. "These will clear the senescent cells. In animal models, they've been shown to be really efficacious in ...
via Bing News